This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Information on how to access Fragmin® (dalteparin sodium) prescribing information and adverse event reporting can be found at the bottom of the page.

Dosing: Haemodialysis and Haemofiltration

Use of Fragmin for the prevention of clotting in the extracorporeal circulation during haemodialysis

Reduce the risk of venous thromboembolism (VTE) in patients undergoing dialysis1

Indication:

Prevention of clotting in the extracorporeal circulation during haemodialysis or haemofiltration, in patients with chronic renal insufficiency or acute renal failure1

Dosage for haemodialysis/haemofiltration1*

*Fragmin does NOT routinely require dose adjustment but caution should be exercised in patients where there is an increased risk of bleeding complications, e.g. in severe renal failure. Monitoring of anti-Xa levels should be considered in patients with renal failure.

Haemodialysis and Haemofiltration

Fragmin Presentations

Discover more

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No